Retraction to: Erucylphosphocholine induces growth inhibition, cell cycle arrest, and apoptosis in human choriocarcinoma cells (Tumor Biol., (2011), 32, (569-574), DOI 10.1007/s13277-010-0152-3);Erucylphosphocholine induces growth inhibition, cell cycle arrest, and apoptosis in human choriocarcinoma cells

Tumor Biology

Volumn 32, Issue 3, 2011, Pages 569-574

  Takai, Noriyuki ^a   Ueda, Tami ^a   Ishii, Terukazu ^a   Kira, Naoko ^a   Nishida, Masakazu ^a   Nasu, Kaei ^a   Narahara, Hisashi ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cell cycle; Choriocarcinoma; Erucylphosphocholine

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ANTINEOPLASTIC AGENT; ERUCYLPHOSPHOCHOLINE; LIPOCORTIN 5; PHOSPHATIDYLSERINE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; PHOSPHORYLCHOLINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CARCINOMA CELL; CELL COUNT; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CELL VIABILITY; CHORIOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG SENSITIVITY; DRUG STRUCTURE; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; PHENOTYPE; PRIORITY JOURNAL; CELL CYCLE; CELL SURVIVAL; PATHOLOGY; PREGNANCY; TUMOR CELL LINE; UTERUS CANCER;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHORIOCARCINOMA; FEMALE; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; PHOSPHORYLCHOLINE; PREGNANCY; UTERINE NEOPLASMS;

EID: 79960594381     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3665-y     Document Type: Erratum

References (24)

1. Jones WB, Cardinale C, Lewis Jr JL. Management of the high-risk gestational trophoblastic disease: the Memorial Hospital experience. Int J Gynecol Cancer. 1997;7:27-33. (Pubitemid 27010014)
2. Berkowitz RS, Goldstein DP, Bernstein MR. Modified triple chemotherapy in the management of high-risk gestational tropho-blastic tumors. Gynecol Oncol. 1984;19:173-81. (Pubitemid 14024343)
3. Surwit EA, Hammond CB. Treatment of metastatic trophoblastic disease with poor prognosis. Obstet Gynecol. 1980;55:565-70. (Pubitemid 10068252)
4. Noseda A, Berens ME, White JG, Modest EJ. In vitro anti-proliferative activity of combinations of ether lipid analogues and DNA-interactive agents against human tumor cells. Cancer Res. 1988;48:1788-91.
5. Jendrossek V, Handrick R. Membrane targeted anticancer drugs: potent inducers of apoptosis and putative radiosensitizers. Curr Med Chem Anticancer Agents. 2003;3:343-53. (Pubitemid 37045712)
6. Jendrossek V, Müller I, Eibl H, Belka C. Intracellular mediators of erucylphosphocholine-induced apoptosis. Oncogene. 2003;22:2621-31.
7. Takai N, Desmond JC, Kumagai T, Gui D, Said JW, Whittaker S, et al. Histone deacetylase inhibitors have a profound anti-growth activity in endometrial cancer cells. Clin Cancer Res. 2004;10:1141-9. (Pubitemid 38198916)
8. Takai N, Ueda T, Nishida M, Nasu K, Narahara H. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med. 2008;21:637-43.
9. Rimon G, Bazenet CE, Philpott KL, Rubin LL. Increased surface phosphatidylserine is an early marker of neuronal apoptosis. J Neurosci Res. 1997;48:563-70. (Pubitemid 27276686)
10. Chen Y, Kramer DL, Diegelman P, Vujcic S, Porter CW. Apoptotic signaling in polyamine analogue-treated SK-MEL-28 human melanoma cells. Cancer Res. 2001;61:6437-44. (Pubitemid 32783249)
11. van Blitterswijk WJ, Verheij M. Anticancer alkylphospholipids: mechanisms of action, cellular sensitivity and resistance, and clinical prospects. Curr Pharm Des. 2008;14:2061-74.
12. Johnson DG, Walker CL. Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol. 1999;39:295-312. (Pubitemid 29222561)
13. Sherr CJ. G1 phase progression: cyclin on cue. Cell. 1994;79:551-5.
14. Erdlenbruch B, Jendrossek V, Gerriets A, Vetterlein F, Eibl H, Lakomek M. Erucylphosphocholine: pharmacokinetics, biodistri-bution, CNS accumulation and toxicity in the rat after intravenous application. Cancer Chemother Pharmacol. 1999;44:484-90.
15. Wang YZ, Chang YB, Xing C, Fu D. The interference effects of hexadecylphosphocholine on proliferation and membrane phos-pholipid metabolism in human myeloid leukemia cell lines. Int J Tissue React. 1998;20:101-7. (Pubitemid 29005396)
16. Lucas L, Hernandez-Alcoceba R, Penalva V, Lacal JC. Modulation of phospholipase D by hexadecylphosphorylcholine: a putative novel mechanism for its antitumoral activity. Oncogene. 2001;20:1110-7. (Pubitemid 32238860)
17. Berkovic D, Bensch M, Bertram J, Wille T, Haase D, Binder C, et al. Effects of hexadecylphosphocholine on thrombocytopoiesis. Eur J Cancer. 2001;37:503-11. (Pubitemid 32232116)
18. Jendrossek V, Kugler W, Erdlenbruch B, Eibl H, Lang F, Lakomek M. Erucylphosphocholine-induced apoptosis in chemo-resistant glioblastoma cell lines: involvement of caspase activation and mitochondrial alterations. Anticancer Res. 2001;21:3389-96. (Pubitemid 34224242)
19. Berkovic D, Grunwald U, Menzel W, Unger C, Hiddemann W, Fleer EAM. Effects of hexadecylphosphocholine on membrane phospholipid metabolism in human tumour cells. Eur J Cancer. 1995;31(A):2080-5. (Pubitemid 26024300)
20. Vink SR, van Blitterswijk WJ, Schellens JHM, Verheij M. Rationale and clinical application of alkylphospholipid analogues in combination with radiotherapy. Cancer Treat Rev. 2007;33:191-202. (Pubitemid 46323398)
21. Handrick R, Rudner J, Müller I, Eibl H, Belka C, Jendrossek V. Bcl-2 mediated inhibition of erucylphosphocholine-induced apo-ptosis depends on its subcellular localization. Biochem Pharmacol. 2005;70:837-50. (Pubitemid 41138848)
22. van der Luit AH, Vink SR, Klarenbeek JB, Perrissoud D, Solary E, Verheij M, et al. A new class of anticancer alkylphospholipids uses lipid rafts as membrane gateways to induce apoptosis in lymphoma cells. Mol Cancer Ther. 2007;6:2337-45. (Pubitemid 47294762)
23. Georgieva MC, Konstantinov SM, Topashka-Ancheva M, Berger MR. Combination effects of alkylphosphocholines and gemcita-bine in malignant and normal hematopoietic cells. Cancer Lett. 2002;182:163-74. (Pubitemid 34621180)
24. Takai N, Ueda T, Nasu K, Narahara H. Erucylphosphocholine shows a strong anti-growth activity in human endometrial and ovarian cancer cells. Gynecol Oncol. 2008;111:336-43.